<DOC>
	<DOCNO>NCT02311959</DOCNO>
	<brief_summary>This phase III , multicentric , single arm study sequential design use exact conditional Poisson test . The primary objective prospective study evaluate whether select breast carcinoma patient could treat nipple spar mastectomy ( NSM ) acceptable low local recurrence rate . 450 patient include period 4 year follow 5 year period ( twice year ) . All patient must complete preoperative evaluation ( bilateral mammography , bilateral breast ultrasonography +/- MRI ) , histopathological diagnostic proof carcinoma ( invasive situ , histopathological type , first treatment relapse ) . The study procedure represent nipple areola skin-sparing mastectomy follow immediate breast reconstruction . After surgery , early late complication , include specific complication ( suffer nipple-areolar complexe suffer skin flap ) , evaluate . An esthetic evaluation ( patient clinician ) quality life evaluation realize throughout study . A complementary study , prospective , non-interventional , proposed patient benefit surgical technique ( NSM ) follow immediate reconstruction , context preventive surgery ( prophylactic surgery patient mutate high genetic risk ) . The aim complementary study , include maximum 60 patient , evaluate associate morbidity prophylactic NSM . Data collect 3 month period surgery .</brief_summary>
	<brief_title>Therapeutic Nipple Sparing Mastectomy .</brief_title>
	<detailed_description />
	<criteria>Patient invasive breast carcinoma stage T1 T2 / situ ( histological type ) prove histopathological diagnosis . Patient indication total mastectomy . Patient without preoperative indication adjuvant radiotherapy accord regional / national guideline . Disease locate 2 cm nipple complete clinical radiologic breast evaluation ( mammography , ultrasound +/ MRI ) . Initial breast cancer recurrence . Patient wish receive immediate breast reconstruction . WHO performance &lt; = 2 . Patient old 40 year . For patient childbearing age , use effective contraceptive method duration study . For patient childbearing potential , negative pregnancy test available inclusion . Patient affiliate social health insurance France . Patient sign informed consent enrollment study specific procedure study . Exclusion Criteria : Positive node physical examination prove cytology . Combination 2 predictive factor postoperative radiotherapy : macroscopic multifocal , grade 2 3 , vascular embolus , overexpressed HER2 ( human epidermal growth factor receptor2 ) , triple negative ( Estrogen Receptor , Progesterone Receptor HER2 negative ) . Neoadjuvant treatment current disease . Patient bilateral breast cancer . Paget disease . T3 T4 carcinoma . Metastatic breast cancer ( disease stag realize accord national regional guideline ) . Breast hypertrophy require nipple support flap . Nursing pregnant woman . Patient participate interventional clinical study . Any psychological , familial , geographic social situation comply medical monitoring and/or procedure study protocol . Patient protect law .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Breast</keyword>
	<keyword>Invasive carcinoma</keyword>
	<keyword>In situ carcinoma</keyword>
	<keyword>Mastectomy</keyword>
	<keyword>Nipple areola</keyword>
	<keyword>Reconstruction</keyword>
	<keyword>Local recurrence</keyword>
</DOC>